News: Oregon’s Bio Boom – ‘Pandemic ready’ industry surpasses $15b footprint creating more firms, more jobs, more investment, more discovery, more innovation

Oregon Bioscience Association released its new economic impact report (posted here) at which points to continued robust growth during the pandemic, with combined economic impacts far outpacing Oregon’s overall economy. Separately, venture capital investment in Oregon and southwest Washington health firms skyrocketed in 2021.

(Portland, Ore. – June 15, 2022) – ‘New’ money flowing to Oregon’s and southwest Washington’s biotech firms and life science research organizations hit its zenith in 2020.

Opinion: How the vaccine has made it all over the world

This commentary, “Opinion: How the vaccine has made it all over the world,” authored by Oregon Bio’s 2022 Chair Dan Snyder, recently ran in the Portland Tribune.

The barriers to people in developing countries getting vaccinated against Covid-19 is decidedly not supply.

Last week, Africa requested all Covid-19 vaccine donations be paused until the third or fourth quarter of this year. John Nkengasong, director of the Africa Centres for Disease Control and Prevention, said the primary challenge for vaccinating the continent is […]

Dr. Emmanuel Akporiaye joins the Oregon Bio board

The Oregon Bioscience Association is pleased to announce that Dr. Akporiaye has joined its Board of Directors

Dr. Emmanuel Akporiaye has over 35  years of experience as a cancer researcher.  His research efforts have focused on understanding the interactions between cancer cells and immune cells that favour tumor growth and spread, and developing novel therapies that are safe, effective, and less toxic while at the same time ensuring that the patient’s quality of life is not compromised. In 2012, Dr. Akporiaye […]

Voice of Industry with OHSU’s Tech Transfer leader

Travis G. Cook recently met with Oregon Bio to discuss OHSU’s tech transfer initiatives. He’s the senior director of Technology Transfer at Oregon Health & Science University, champions research and development by promoting an innovative and entrepreneurial culture.  Prior to OHSU, he served as director of business development at Galena Biopharma (Nasdaq: GALE), an adjunct professor at University of Portland bringing concepts of tech commercialization in the school’s Technology Entrepreneurship Certification program with previous appointments at Kalypsys, Inc., Ansata Therapeutics, […]